Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Teva pays $460mm for controlling interest in Japanese generic maker Taiyo

Executive Summary

A few weeks after speculation surfaced, Teva Pharmaceutical Industries Ltd. announced a definitive agreement to acquire 57% of private Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd. for $460mm in cash. Teva plans to eventually buy the rest of Taiyo. The deal gives Taiyo an enterprise value of $1.3bn.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies